Key facts
- bitBiome’s last known valuation is $29.9M (Jan 2025).
- It has raised $16.1M; the latest was Accelerator/Incubator in Jul 2025.
- Notable investors include Plug and Play Tech Center, Global Brain, In-Q-Tel, Pegasus Tech Ventures, The University of Tokyo Edge Capital — 17 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for bitBiome
- ·The full record, as it builds
Funding rounds
No funding rounds for bitBiome are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About bitBiome
Provider of microbial genome analysis intended for research and industrial applications. The company utilizes single-cell sequencing technology to decode without the need for isolation or cultivation, enabling healthcare providers to advance research, drug discovery and sustainable innovations.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2018
- Employees
- 45
- Website
- bitbiome.co.jp/
- Ownership
- Privately Held (backing)
bitBiome doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in bitBiome shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on bitBiome in its N-PORT filings yet. We sweep new filings monthly.